• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Twist Bioscience Corp (NQ: TWST )

    45.52 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 17, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 45.52
    Bid (Size) 43.00 (1)
    Ask (Size) 48.70 (1)
    Prev. Close 45.52
    Today's Range 45.52 - 45.52
    52wk Range 14.42 - 60.90
    Shares Outstanding 50,885,068
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer
    From Twist Bioscience Corporation
    Via Business Wire
    Deep Dive Into Twist Bioscience Stock: Analyst Perspectives (5 Ratings)
    Via Benzinga

    Performance

    YTD
    +31.41%
    +31.41%
    1 Month
    -4.51%
    -4.51%
    3 Month
    -15.01%
    -15.01%
    6 Month
    +60.51%
    +60.51%
    1 Year
    +165.42%
    +165.42%

    More News

    Read More
    Coeur Mining, Medical Properties Trust And RH Are Among Top 7 Mid Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?
    Via Benzinga
    Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance
    From Twist Bioscience Corporation
    Via Business Wire
    Evaluating Twist Bioscience: Insights From 5 Financial Analysts
    Via Benzinga
    Key Takeaways From Twist Bioscience Analyst Ratings
    Via Benzinga
    Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels
    From Twist Bioscience Corporation
    Via Business Wire
    Twist Bioscience to Present at Baird Global Healthcare Conference 2024
    From Twist Bioscience Corporation
    Via Business Wire
    How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates
    Via FinancialNewsMedia
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates
    From FN Media Group LLC
    Via GlobeNewswire
    Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb
    From Twist Bioscience Corporation
    Via Business Wire
    3 Healthcare AI Stocks Positioned for Potential Breakthroughs
    Via InvestorPlace
    Topics Artificial Intelligence Economy
    Exposures Artificial Intelligence Interest Rates
    Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    From Twist Bioscience Corporation
    Via Business Wire
    Sotera Health Posts Upbeat Results, Joins Thoughtworks, Sonic Automotive And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    The 3 Best Med Tech Stocks to Buy Now
    Via InvestorPlace
    Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis
    From Twist Bioscience Corporation
    Via Business Wire
    Twist Bioscience Beats Q3 Earnings Forecast, Plans To Achieve 50% Gross Margin By Fiscal Year 2025
    Via Benzinga
    Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results
    From Twist Bioscience Corporation
    Via Business Wire
    Biotech Bull Market Is Intact But SMIDs Are Too Volatile
    Via Talk Markets
    Twist Bioscience Announces Clinical Progression of Pure Biologics’ Antibody Candidate Discovered Using Twist’s Antibody Libraries
    From Twist Bioscience Corporation
    Via Business Wire
    Twist Bioscience to Report Fiscal 2024 Third Quarter Financial Results on Friday, August 2, 2024
    From Twist Bioscience Corporation
    Via Business Wire
    Cathie Wood Touts Palantir, Coinbase And Roku As ARK's Flagship Fund Shifts Focus From Mag 6 Amid 'Whiff' Of Lower Interest Rates
    Via Benzinga
    Topics ETFs
    Twist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express Antibodies
    From Twist Bioscience Corporation
    Via Business Wire
    Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A
    From Twist Bioscience Corporation
    Via Business Wire
    Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.